Which COVID studies pose a biohazard? Lack of clarity hampers research

Posted on AllSides October 25th, 2022
From The Center
National Institutes of Health/Science Photo Library

When researchers at Boston University (BU) in Massachusetts inserted a gene from the Omicron variant of SARS-CoV-2 into a strain of the virus from the beginning of the pandemic, they were trying to understand why Omicron causes mild disease.

But the experiments, described in a 14 October preprint1, have ignited a red-hot controversy over what constitutes truly risky SARS-CoV-2 research — especially now that much of the world’s population has some immune protection from the virus and COVID-19 treatments are available.

Read full story


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for Nature.com
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right